Posts with tag: interview preparation
BioMarin Pharmaceutical (NASDAQ: BMRN) reported strong Q4 results, beating analyst estimates for both revenue and EPS. The company's full-year revenue guidance came in above expectations, and its adjusted EPS guidance for the upcoming year is also above estimates. BioMarin's key takeaways for Q4 include revenue growth of 15.6% year-over-year, adjusted EPS of $0.92 vs. estimates of $0.74, revenue guidance of $3.15 billion, and adjusted EPS guidance of $4.30.
Published on: February 19, 2025, 10:11 PM UTC
Vanguard Cuts Fees on 168 Mutual Funds and ETFs, Lowering Average Ratio to 0.07%
Published on: February 06, 2025, 04:03 PM UTC
Apple shares climbed in Frankfurt after the tech giant predicted strong sales growth in the current quarter, indicating a rebound from a decline in iPhone sales.
Published on: January 31, 2025, 08:00 AM UTC
China announces new measures to promote index investment products, including reducing costs and exempting market-making fees, to boost ailing equity market amid external economic environment.
Published on: January 26, 2025, 03:02 PM UTC